Page 6 - Pharmaceutical Firms

Zydus Cadila gets USFDA nod to market generic antihistamine tablets

The drug will be manufactured at the group's manufacturing facility in Ahmedabad

Sanofi eyes Covid-19 vaccine approval in early 2021; partners Translate Bio

Many drugmakers are racing to come up with a safe and effective vaccine that can be produced at large scale

Piramal Pharma Solutions to acquire G&W Laboratories' drug facility in US

The site has received certifications from the Food and Drug Administration and European Medicines Agency

Needed: A fresh look at the services sector

A post Covid-19 foreign trade policy must be cognisant of the evolving opportunities and challenges in services trade and must prepare domestic policies and capacity accordingly

Covid-19 impact: Exports dip 60% in Apr, iron ore, pharma only bright spots

Apart from exports, imports too, tumbled 58.7% in April, with all major import products seeing a contraction.

Chinese exceptionalism

Trade ties with China are mutually beneficial but the world should seek transparency about that country's institutions

CordenPharma extends Moderna deal to supply lipids to produce Covid vaccine

The expanded agreement will be effective immediately to help meet Moderna's increasing demand over the coming months

Zydus supplies first batch of 30,000 Covid Kavach Elisa tests to ICMR

Robust antibody tests are critical for surveillance and understanding the proportion of the population exposed to SARS Cov-2 infection

Britain's AstraZeneca to make bn Covid-19 vaccine doses if tests succeed

Drugmaker says it had signed the first agreements to supply at least 400 million doses of the vaccine, which it is developing with Oxford University.

Strides Pharma to conduct trials for potential Covid-19 drug Favipiravir

Favipiravir is manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug in the country in 2014

Pfizer to outsource some drug production, focus on coronavirus vaccine

Pfizer and German partner BioNTech SE (22UAy.F) said on Tuesday they have begun delivering doses of their coronavirus vaccine candidates for initial human testing in the United States.

Mumbai docs try Biocon and Roche's biologic drugs on critical Covid cases

Two repurposed drugs for rheumatoid arthritis and psoriasis are being tried on over 100 patients in Mumbai

Vaccinating policy

IP regimes should not outweigh public health interests

Patents vs the pandemic

We should question the wisdom and morality of a system that silently condemns millions of human beings to suffering

Pharma traders seek IT rule exemption as retailers pay stockists in cash

They fear scrutiny by tax authorities at a later date, assure that the relaxation will not be misused

Investors should stick to stocks of firms focused on domestic market

Pharma firms can build brands and enjoy higher margins here

Covid-19: 26 Navy sailors test positive; no cases on combat ships

India tally nears 15,000-mark

Drug regulator asks traders to stock 55 ICU drugs for Covid-19 treatment

These drugs are in addition to the requirement to hydroxychloroquine and Azithromycin for patients, healthcare workers and household contacts of positive cases

Race for vaccine against coronavirus heats up in India; 6 firms in the fray

With vaccines of some firms already in the animal trial phase, developers say that if all goes well, India can have a vaccine by next year, ahead of the earlier timelines

India's only quinine making unit set up in 1874, has been shut since 2001

Covid-19 has triggered a sense of urgency to revive this sick unit, as Hydroxychloroquine, an anti-malarial drug, surfaced as potential medicine to alleviate the symptoms of the disease